Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Highbridge Capital Lays Off 3 Senior Execs and 3 Analysts

Highbridge Capital Management is making some big changes after its long/short equity fund reported lackluster performance in 2011.

The Highbridge Capital fund which is managed by Glenn Russell Dubin, has laid off three senior executives, including two portfolio managers, and at least three analysts and traders as the long/short fund continues to struggle according to AR Magazine. The dismissals were centered on Highbridge Capital Management’s $1.8 billion long/short equity fund, which is down 12.6% so far this year. HIGHBRIDGE CAPITAL MANAGEMENT

Jennifer Failla, a portfolio manager who covered the retail sector, Chris Storey, an analyst who covered financials and Don Kuzoian, an analyst who covered the technology sector, were amongst those dismissed.

Highbridge’s long/short equity fund wasn’t the only fund to lose money this year. Hedge fund performance in November was disappointing at best. In fact, hedge fund performance was more disappointing than any time since the end of the Lehman Brothers (see more details here). Hedge funds have failed to deliver impressive returns, and it becomes more difficult for them to bet or remain their previous earns. At the same time, the market was roughly level through the first 11 months of the year, losing just 0.21% from January 1 to December 1. Changing up fund staff is the next logical step with fund performance falling so far below market performance. The only question is how many other funds will change things up for the new year.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!